Literature DB >> 18318990

The classical and regulatory functions of C1q in immunity and autoimmunity.

Jin Hua Lu1, Boon King Teh, Lin da Wang, Yi Nan Wang, Yen Seah Tan, Min Chern Lai, Kenneth B M Reid.   

Abstract

A classical function of C1q is to bind immune complexes and initiate complement activation producing membrane lytic complexes, opsonins and anaphylatoxins. This classical pathway of complement activation is also elicited when C1q binds some other ligands. Besides complement activation, C1q also regulates cell differentiation, adhesion, migration, activation and survival. C1q deficiency is associated with autoimmunity as well as increased susceptibility to infections. In this article, we discuss the basic properties of C1q, its expression, and classical and regulatory functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18318990      PMCID: PMC4652917          DOI: 10.1038/cmi.2008.2

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  46 in total

1.  Complement C1q enhances homing-related responses of hematopoietic stem/progenitor cells.

Authors:  Ali Jalili; Leah Marquez-Curtis; Neeta Shirvaikar; Marcin Wysoczynski; Mariusz Ratajczak; Anna Janowska-Wieczorek
Journal:  Transfusion       Date:  2010-09       Impact factor: 3.157

2.  Gene therapy for retinitis pigmentosa caused by MFRP mutations: human phenotype and preliminary proof of concept.

Authors:  Astra Dinculescu; Jackie Estreicher; Juan C Zenteno; Tomas S Aleman; Sharon B Schwartz; Wei Chieh Huang; Alejandro J Roman; Alexander Sumaroka; Qiuhong Li; Wen-Tao Deng; Seok-Hong Min; Vince A Chiodo; Andy Neeley; Xuan Liu; Xinhua Shu; Margarita Matias-Florentino; Beatriz Buentello-Volante; Sanford L Boye; Artur V Cideciyan; William W Hauswirth; Samuel G Jacobson
Journal:  Hum Gene Ther       Date:  2012-01-26       Impact factor: 5.695

Review 3.  C1q nephropathy in the pediatric population: pathology and pathogenesis.

Authors:  Scott E Wenderfer; Rita D Swinford; Michael C Braun
Journal:  Pediatr Nephrol       Date:  2010-02-24       Impact factor: 3.714

4.  Activation of the classical complement pathway by Bacillus anthracis is the primary mechanism for spore phagocytosis and involves the spore surface protein BclA.

Authors:  Chunfang Gu; Sarah A Jenkins; Qiong Xue; Yi Xu
Journal:  J Immunol       Date:  2012-03-21       Impact factor: 5.422

5.  C1q limits dendritic cell differentiation and activation by engaging LAIR-1.

Authors:  Myoungsun Son; Frances Santiago-Schwarz; Yousef Al-Abed; Betty Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-23       Impact factor: 11.205

6.  Analysis of human C1q by combined bottom-up and top-down mass spectrometry: detailed mapping of post-translational modifications and insights into the C1r/C1s binding sites.

Authors:  Delphine Pflieger; Cédric Przybylski; Florence Gonnet; Jean-Pierre Le Caer; Thomas Lunardi; Gérard J Arlaud; Régis Daniel
Journal:  Mol Cell Proteomics       Date:  2009-12-14       Impact factor: 5.911

7.  Anti-C1q autoantibodies are linked to autoimmune thyroid disorders in pregnant women.

Authors:  H Vitkova; J Jiskra; D Springer; Z Limanova; Z Telicka; J Bartakova; M Trendelenburg; E Potlukova
Journal:  Clin Exp Immunol       Date:  2016-08-12       Impact factor: 4.330

8.  Surfactant protein A influences reepithelialization in an alveolocapillary model system.

Authors:  Coen H M P Willems; Luc J I Zimmermann; Renate M R Langen; Maria J A van den Bosch; Nico Kloosterboer; Boris W Kramer; J Freek van Iwaarden
Journal:  Lung       Date:  2012-10-13       Impact factor: 2.584

Review 9.  Complement and autoimmunity.

Authors:  Eleonora Ballanti; Carlo Perricone; Elisabetta Greco; Marta Ballanti; Gioia Di Muzio; Maria Sole Chimenti; Roberto Perricone
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

10.  Essential role of mannose-binding lectin-associated serine protease-1 in activation of the complement factor D.

Authors:  Minoru Takahashi; Yumi Ishida; Daisuke Iwaki; Kazuko Kanno; Toshiyuki Suzuki; Yuichi Endo; Yoshimi Homma; Teizo Fujita
Journal:  J Exp Med       Date:  2009-12-28       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.